重大疾病治疗药物研发商
2026.01.23,RTW Investments,SR One,RA Capital Management,HBM Healthcare Investments AG,TCG Crossover,SymBiosis
2024.09.19,普洛药业
2024.01.07,RTW Investments,Bayer拜耳
2024.01.06,拜耳,RTW Investments
2021.07.01,RTW Investments
说明:依据网络公开报道数据收集而来,仅供参考。